Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT.

Saved in:
Bibliographic Details
Title: Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT.
Authors: Farhan S; Stem Cell Transplant & Cellular Therapy Program, Henry Ford Health, Detroit, Michigan. Electronic address: sfarhan1@hfhs.org., Kennedy VE; Division of Blood and Marrow Transplant and Cellular Therapy, Stanford University, Stanford, California., Espinoza-Gutarra MR; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, Alabama., Lust H; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Bobillo MSO; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Lin AY; Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois., Olin RL; University of California San Francisco Helen Diller Comprehensive Cancer Center, San Francisco, CA., Lin RJ; Memorial Sloan Kettering Cancer Center, New York City, New York., Rentscher KE; Department of Psychiatry and Behavioral Medicine, MCW Cancer Center Scholar, Medical College of Wisconsin, Milwaukee, Wisconsin., Taylor MR; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, Washington., Mohanraj L; School of Nursing, Virginia Commonwealth University and VCU Massey Comprehensive Cancer Center, Richmond, Virginia., Wood WA; Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Murthy HS; Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, Florida., Ahmed N; Division of Hematological Malignancies and Cellular Therapeutics, Department of Internal Medicine, US., Dueck AC; Mayo Clinic, Scottsdale, Arizona., Phelan R; Department of Pediatrics, Division of Hematology/Oncology/Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, Wisconsin., Kelly DL; Loewenberg College of Nursing, University of Memphis, Memphis, Tennessee., Yuen C; Hematology and oncology, Neal Cancer Center, Houston Methodist Hospital, Houston, Texas., Munshi PN; Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, Pennsylvania., Schoemans H; Department of Hematology, University Hospitals Leuven, Leuven, Belgium; department of Public Health and Primary Care, ACCENT VV, KU Leuven - University of Leuven, Leuven, Belgium., Hamilton BK; Department of Hematology/Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio., Lee C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington., Sung AD; Division of Hematological Malignancies and Cellular Therapeutics, Department of Internal Medicine, US.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2025 Oct; Vol. 31 (10), pp. 742-755. Date of Electronic Publication: 2025 Jun 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2025.06.017